www.statnews.com
Open in
urlscan Pro
2606:4700::6812:1b65
Public Scan
Submitted URL: https://link.morningbrew.com/click/26963222.149018/aHR0cHM6Ly93d3cuc3RhdG5ld3MuY29tLzIwMjIvMDMvMDQvbWljcm9zb2Z0LWNsb3Nlcy0xNi...
Effective URL: https://www.statnews.com/2022/03/04/microsoft-closes-16-billion-acquisition-nuance-communications/?utm_source=STAT%20News...
Submission: On March 11 via api from US — Scanned from DE
Effective URL: https://www.statnews.com/2022/03/04/microsoft-closes-16-billion-acquisition-nuance-communications/?utm_source=STAT%20News...
Submission: On March 11 via api from US — Scanned from DE
Form analysis
2 forms found in the DOMGET https://www.statnews.com/
<form class="header-search search-form" role="search" method="get" action="https://www.statnews.com/">
<input type="search" class="search-form-field" placeholder="Search …" value="" name="s" aria-label="Search …">
<button type="submit" class="header-btn header-btn-search">Search</button>
<button class="header-btn header-btn-back">Cancel</button>
</form>
POST
<form id="coral-display-name-form" class="coral-display-name-form stat-form" method="post">
<input type="text" id="enter-display-name-input" name="display" placeholder="Create a display name" value="">
<p id="enter-display-name-error" style="display: none">There was an error saving your display name. Please check and try again.</p>
<input type="submit" value="Continue">
</form>
Text Content
Skip to Main Content * * * * Community Try STAT+ TODAY * Contribute * Log In * Try STAT+ TODAY My Account * My Account * Billing * Log In Try STAT+ TODAY My Account Search Cancel * TOPICS * Coronavirus * Health * Pharma * Biotech * Politics & Policy * Health Tech * In the Lab * Business * Artificial Intelligence * Vaccines * Health Disparities * Prescription Politics * OPINION * First Opinion * The Pharmalot View * Adam's Take * Matt's Take * Off the Charts * TEAM * Biotech & Pharma * Adam Feuerstein * Damian Garde * Matthew Herper * Meghana Keshavan * Kate Sheridan * Ed Silverman * Jonathan Wosen * Health Tech * Mario Aguilar * Katie Palmer * Mohana Ravindranath * Casey Ross * Business & Policy * Rachel Cohrs * Lev Facher * Nicholas Florko * Bob Herman * Health & Science * Eric Boodman * Helen Branswell * Angus Chen * Elizabeth Cooney * Isabella Cueto * Theresa Gaffney * Olivia Goldhill * Andrew Joseph * Megan Molteni * Usha Lee McFarling * Jennifer Adaeze Okwerekwu * Nicholas St. Fleur * Team * View All * EVENTS * STAT Events * 2022 STAT Breakthrough Science Summit * Industry Events Calendar * View all Summits * Webinars * PODCASTS * The Readout LOUD * First Opinion Podcast * NEWSLETTERS * RESOURCES * STAT Trials Pulse * Reports * E-books * VIDEO * * STAT+ * Exclusive analysis of biotech, pharma, and the life sciences Learn More * The Latest * My Account * Topics * Biotech * Pharma * Policy * Health Tech * Business * Columns * Adam's Take * Matt's Take * The Pharmalot View * Tools * CRISPR Trackr * Drug Pricing Policy Cheat Sheet * Events * STAT+ Conversations * All STAT Events * Team * Biotech and Pharma * Health Tech * Politics and Policy * Health and Science Account * My Account * Billing * Subscribe * Log In * Help More * Community * Contribute * Group Subscriptions Follow Us * * * * * Trending: Coronavirus Pharmalot First Opinion Biotech Subscribe Now To access exclusive content, subscribe to STAT+ View Latest View the latest STAT+ stories In-depth analysis of biotech, pharma, and the life sciences * AWARD-WINNING JOURNALISM from some of the nation's most trusted and well-connected reporters in the industry * WEEKLY LIVE VIDEO CHATS with STAT+ reporters and leading industry experts in our STAT+ Conversations series * EXCLUSIVE INDUSTRY EVENTS hosted by STAT+, plus early-bird access and discounts to industry events around the country * DAILY STAT+ NEWSLETTERS get delivered to your inbox to brief you on the most important industry news of the day * PREMIUM DATA TOOLS like our CRISPR Trackr and Drug Pricing Policy Tracker EXCLUSIVE COVERAGE AND ANALYSIS OF BIOTECH, PHARMA, AND THE LIFE SCIENCES Try STAT+ 30 days FREE Learn More In-depth analysis of biotech, pharma, and the life sciences * AWARD-WINNING JOURNALISM from some of the nation's most trusted and well-connected reporters in the industry * WEEKLY LIVE VIDEO CHATS with STAT+ reporters and leading industry experts in our STAT+ Conversations series * EXCLUSIVE INDUSTRY EVENTS hosted by STAT+, plus early-bird access and discounts to industry events around the country * DAILY STAT+ NEWSLETTERS get delivered to your inbox to brief you on the most important industry news of the day * PREMIUM DATA TOOLS like our CRISPR Trackr and Drug Pricing Policy Tracker EXCLUSIVE COVERAGE AND ANALYSIS OF BIOTECH, PHARMA, AND THE LIFE SCIENCES Try STAT+ 30 days FREE Learn More Health Tech MICROSOFT CLOSES $16B ACQUISITION OF NUANCE, LAUNCHING A BOLD EXPERIMENT IN HEALTH AI * By Casey Ross March 4, 2022 Reprints * + Comments * * * * * * * * JOSEP LAGO/AFP via Getty Images * 0 Comments * * * * * * * * AI’s next big health care experiment can now begin. Microsoft closed on a $16 billion acquisition of Nuance Communications Friday, launching a plan to leverage its speech recognition software and other AI capabilities to seize what the tech giant sees as a $500 billion market opportunity. Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+. First 30 days free. GET STARTED Log In * 0 Comments * * * * * * * * ABOUT THE AUTHOR REPRINTS CASEY ROSS National Technology Correspondent Casey covers the use of artificial intelligence in medicine and its underlying questions of safety, fairness, and privacy. He is the co-author of the newsletter STAT Health Tech. casey.ross@statnews.com @caseymross TAGS Health IT medical technology STAT+ Add a Comment CREATE A DISPLAY NAME TO COMMENT This name will appear with your comment There was an error saving your display name. Please check and try again. EXCLUSIVE BIOPHARMA, HEALTH POLICY, AND LIFE SCIENCE ANALYSIS. START YOUR 30-DAY FREE TRIAL TODAY. TRY STAT+ CATCH UP ON THE LATEST MUST-READ COVERAGE AND ANALYSIS Read Now advertisement * Congress considers a longer phase-out of looser, Covid-era telehealth policies * Congress moves toward giving FDA authority over synthetic nicotine products like Puff Bar * Pharmalittle: Bankruptcy court judge OKs Purdue settlement; U.S. Senate revives legislation to curb insulin costs Learn more about STAT+ advertisement Trending Gaslighting of Black medical trainees makes residency something to… Gaslighting of Black medical trainees makes residency something to ‘survive’ Human reproductive cloning: The curious incident of the dog… Human reproductive cloning: The curious incident of the dog in the night-time Pharmalittle: Bankruptcy court judge OKs Purdue settlement; U.S. Senate… Pharmalittle: Bankruptcy court judge OKs Purdue settlement; U.S. Senate revives legislation to curb insulin costs Recommended As providers are accused of interfering with access to… As providers are accused of interfering with access to patient data, pressure builds on government to… Dozens of towns and counties object to ‘hush money’… Dozens of towns and counties object to ‘hush money’ tied to Purdue opioid settlement Gilead’s Dan O’Day is pharma’s most charming executive —… Gilead’s Dan O’Day is pharma’s most charming executive — but with his deals falling apart, charm… RECOMMENDED STORIES Matt's Take GILEAD’S DAN O’DAY IS PHARMA’S MOST CHARMING EXECUTIVE — BUT WITH HIS DEALS FALLING APART, CHARM MAY NOT BE ENOUGH By Matthew Herper Pharmalot PHARMALITTLE: U.S. LAWMAKER PROPOSES BILL TO CURTAIL FDA’S ACCELERATED APPROVAL; MODERNA TO ENFORCE COVID PATENTS IN WEALTHY COUNTRIES By Ed Silverman advertisement Biotech WITH ADUHELM IN LIMBO, BIOGEN STARTS LAYING OFF EMPLOYEES By Adam Feuerstein and Damian Garde Special Report WHY FORMALLY ENDING THE PANDEMIC IS GOING TO BE A HUGE HEADACHE FOR THE ENTIRE HEALTH CARE SYSTEM By Rachel Cohrs Biotech UC BERKELEY LOSES CRISPR PATENT CASE, INVALIDATING PATENT RIGHTS IT GRANTED GENE-EDITING COMPANIES DEVELOPING HUMAN THERAPIES By Megan Molteni Reporting from the frontiers of health and medicine Trending: * Coronavirus * Pharmalot * First Opinion * Biotech * Pharma * Health Back to top COMPANY * About STAT * Awards * Contact Us * Careers & Internships * Contribute * Diversity & Inclusion * Licensing Stories * Our Team ACCOUNT * About STAT+ * FAQs * Log In * Subscribe APP & OTHER PRODUCTS * STAT App * Newsletters * Podcasts * STAT Madness * STAT Reports * STAT Trials Pulse * STAT Wunderkinds GROUP SUBSCRIPTIONS * Contact Us * Request A Quote ADVERTISING * Advertise With Us * Download Media Kit EVENTS * Industry Events Calendar * STAT Events * STAT Summits * Sponsor An Event * Privacy * Comment Policy * Terms * Do Not Sell my Data * ©2022 STAT * * * * * Please review our cookie policy We use first- and third-party cookies to customize your experience and display advertising. By continuing to use the site, you agree to our use of cookies. If you want to know more or opt out in whole or in part, please see our Privacy Notice and our Cookie FAQ. Accept No thanks